{"success":true,"data":{"pressRelease":{"id":"154590","rtpr_id":"nPn26hdtta-20260928","ticker":"FMC","exchange":"NYSE","all_tickers":["FMC"],"title":"FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil","author":"PR Newswire","published_at":"2026-09-28T20:30:00.232Z","article_body":"FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil\nPR Newswire\n\nPHILADELPHIA, Sept. 28, 2026\n\nSecond global filing advances rimisoxafen as a novel weed control solution for\nBrazil's more than 70 million hectares of corn and soybeans\n\nPHILADELPHIA, Sept. 28, 2026 /PRNewswire/ --\n\nFMC Corporation (NYSE: FMC), a leading global agricultural sciences company,\ntoday announced the submission of the regulatory dossier for rimisoxafen to\nBrazilian regulatory authorities. The filing marks the second global\nregulatory submission for rimisoxafen, the first and only dual mode of action\nherbicide, following FMC's submission to the U.S. Environmental Protection\nAgency in July 2026.\n\nBrazil is among the world's largest soybean and corn markets, with\napproximately 50 million hectares of soybean and over 20 million hectares of\ncorn in production. Growers are facing mounting pressure from resistant\nbroadleaf weeds, including Amaranthus hybridus, which has developed\nresistance to glyphosate and acetolactate synthase inhibitors,\nand Amaranthus palmeri, a regulated quarantine weed posing a significant and\ngrowing threat to crop productivity.\n\n\"Brazilian growers are facing complex weed resistance challenges that demand\nnew and differentiated solutions,\" said Leonardo Bastos, vice president and\nchief marketing officer at FMC. \"Submitting rimisoxafen for regulatory review\nin Brazil is an important step forward, demonstrating our long-term commitment\nto this market and to the growers who depend on innovation to protect their\ncrops and their livelihoods.\"\n\nClassified by the Herbicide Resistance Action Committee under Groups 12 and\n32, rimisoxafen offers growers a novel tool to help diversify weed management\nprograms and support long-term resistance management. In extensive FMC field\ntesting, rimisoxafen has demonstrated consistent activity against small seeded\nbroadleaf weeds and those resistant to other herbicides, including Amaranthus\npalmeri and Amaranthus hybridus.\n\nRimisoxafen is the third novel herbicide active ingredient FMC has advanced to\nregulatory submission in Brazil, following Isoflex™ active and Dodhylex™\nactive. Together, these submissions reflect the depth and productivity of\nFMC's research and development pipeline and the company's commitment to\nadvancing next-generation crop protection solutions through the regulatory\nprocess.\n\nFormulated product submissions for rimisoxafen are expected to follow as the\nregulatory process advances in Brazil. Timing and outcomes remain subject to\nregulatory review and approval. Rimisoxafen is not registered for sale or use\nin Brazil or any other country. No offer for sale, sale or use of this product\nis permitted prior to receipt of all required regulatory approvals.\n\nAbout FMC\n\nFMC Corporation is a global agricultural sciences company dedicated to helping\ngrowers produce food, feed, fiber and fuel for an expanding world population\nwhile adapting to a changing environment. FMC's innovative crop protection\nsolutions – including biologicals, crop nutrition, digital and precision\nagriculture – enable growers and crop advisers to address their toughest\nchallenges economically while protecting the environment. FMC is committed to\ndiscovering new herbicide, insecticide and fungicide active ingredients,\nproduct formulations and pioneering technologies that are consistently better\nfor the planet. Visit fmc.com to learn more and follow us on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4784034-1&h=2024898182&u=https%3A%2F%2Fwww.linkedin.com%2Fschool%2Ffmc-corporation%2F&a=LinkedIn)\n(®).\n\nIsoflex and Dodhylex are trademarks of FMC Corporation and/or an affiliate.\nAlways read and follow all label directions, restrictions and precautions for\nuse. Products listed here may not be registered for sale or use in all states,\ncountries or jurisdictions.\n\nStatement under the Safe Harbor Provisions of the Private Securities\nLitigation Reform Act of 1995:  FMC and its representatives may from time to\ntime make written or oral statements that are \"forward-looking\" and provide\nother than historical information, including statements contained in this\npress release, in FMC's other filings with the SEC, and in presentations,\nreports or letters to FMC stockholders.\n\nIn some cases, FMC has identified these forward-looking statements by such\nwords or phrases as \"outlook\", \"will likely result,\" \"is confident that,\"\n\"expect,\" \"expects,\" \"should,\" \"could,\" \"may,\" \"will continue to,\" \"believe,\"\n\"believes,\" \"anticipates,\" \"predicts,\" \"forecasts,\" \"estimates,\" \"projects,\"\n\"potential,\" \"intends\" or similar expressions identifying \"forward-looking\nstatements\" within the meaning of the Private Securities Litigation Reform Act\nof 1995, including the negative of those words or phrases. Such\nforward-looking statements are based on our current views and assumptions\nregarding future events, future business conditions and the outlook for the\ncompany based on currently available information. The forward-looking\nstatements involve known and unknown risks, uncertainties and other factors\nthat may cause actual results to be materially different from any results,\nlevels of activity, performance or achievements expressed or implied by any\nforward-looking statement. These statements are qualified by reference to the\nrisk factors included in Part I, Item 1A of our Annual Report on Form 10-K for\nthe year ended December 31, 2025 (the \"2025 Form 10-K\"), the section captioned\n\"Forward-Looking Information\" in Part II of the 2025 Form 10-K and to similar\nrisk factors and cautionary statements in all other reports and forms filed\nwith the Securities and Exchange Commission (\"SEC\"). We wish to caution\nreaders not to place undue reliance on any such forward-looking statements,\nwhich speak only as of the date made.  Forward-looking statements are\nqualified in their entirety by the above cautionary statement.\n\nWe specifically decline to undertake any obligation, and specifically\ndisclaims any duty, to publicly update or revise any forward-looking\nstatements that have been made to reflect events or circumstances after the\ndate of such statements or to reflect the occurrence of anticipated or\nunanticipated events, except as may be required by law.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/fmc-corporation-submits-regulatory-dossier-for-rimisoxafen-the-industrys-first-dual-mode-of-action-herbicide-in-brazil-302891817.html\n(https://www.prnewswire.com/news-releases/fmc-corporation-submits-regulatory-dossier-for-rimisoxafen-the-industrys-first-dual-mode-of-action-herbicide-in-brazil-302891817.html)\n\nSOURCE FMC Corporation\n\n\n\nMedia contact: Kaitlin O'Shaughnessy, +1 (215) 299-6405, Kaitlin.OShaughnessy@fmc.com; Investor contact: Curt Brooks, +1 (215) 299-6137, Curt.Brooks@fmc.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS254577/FMC-CORPORATION-LOGO.jpg?id=OA2973644\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn26hdtta-20260928","title":"FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil","author":"PR Newswire","ticker":"FMC","created":"2026-09-28T20:30:00.232Z","tickers":["FMC"],"exchange":"NYSE","article_body":"FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil\nPR Newswire\n\nPHILADELPHIA, Sept. 28, 2026\n\nSecond global filing advances rimisoxafen as a novel weed control solution for\nBrazil's more than 70 million hectares of corn and soybeans\n\nPHILADELPHIA, Sept. 28, 2026 /PRNewswire/ --\n\nFMC Corporation (NYSE: FMC), a leading global agricultural sciences company,\ntoday announced the submission of the regulatory dossier for rimisoxafen to\nBrazilian regulatory authorities. The filing marks the second global\nregulatory submission for rimisoxafen, the first and only dual mode of action\nherbicide, following FMC's submission to the U.S. Environmental Protection\nAgency in July 2026.\n\nBrazil is among the world's largest soybean and corn markets, with\napproximately 50 million hectares of soybean and over 20 million hectares of\ncorn in production. Growers are facing mounting pressure from resistant\nbroadleaf weeds, including Amaranthus hybridus, which has developed\nresistance to glyphosate and acetolactate synthase inhibitors,\nand Amaranthus palmeri, a regulated quarantine weed posing a significant and\ngrowing threat to crop productivity.\n\n\"Brazilian growers are facing complex weed resistance challenges that demand\nnew and differentiated solutions,\" said Leonardo Bastos, vice president and\nchief marketing officer at FMC. \"Submitting rimisoxafen for regulatory review\nin Brazil is an important step forward, demonstrating our long-term commitment\nto this market and to the growers who depend on innovation to protect their\ncrops and their livelihoods.\"\n\nClassified by the Herbicide Resistance Action Committee under Groups 12 and\n32, rimisoxafen offers growers a novel tool to help diversify weed management\nprograms and support long-term resistance management. In extensive FMC field\ntesting, rimisoxafen has demonstrated consistent activity against small seeded\nbroadleaf weeds and those resistant to other herbicides, including Amaranthus\npalmeri and Amaranthus hybridus.\n\nRimisoxafen is the third novel herbicide active ingredient FMC has advanced to\nregulatory submission in Brazil, following Isoflex™ active and Dodhylex™\nactive. Together, these submissions reflect the depth and productivity of\nFMC's research and development pipeline and the company's commitment to\nadvancing next-generation crop protection solutions through the regulatory\nprocess.\n\nFormulated product submissions for rimisoxafen are expected to follow as the\nregulatory process advances in Brazil. Timing and outcomes remain subject to\nregulatory review and approval. Rimisoxafen is not registered for sale or use\nin Brazil or any other country. No offer for sale, sale or use of this product\nis permitted prior to receipt of all required regulatory approvals.\n\nAbout FMC\n\nFMC Corporation is a global agricultural sciences company dedicated to helping\ngrowers produce food, feed, fiber and fuel for an expanding world population\nwhile adapting to a changing environment. FMC's innovative crop protection\nsolutions – including biologicals, crop nutrition, digital and precision\nagriculture – enable growers and crop advisers to address their toughest\nchallenges economically while protecting the environment. FMC is committed to\ndiscovering new herbicide, insecticide and fungicide active ingredients,\nproduct formulations and pioneering technologies that are consistently better\nfor the planet. Visit fmc.com to learn more and follow us on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4784034-1&h=2024898182&u=https%3A%2F%2Fwww.linkedin.com%2Fschool%2Ffmc-corporation%2F&a=LinkedIn)\n(®).\n\nIsoflex and Dodhylex are trademarks of FMC Corporation and/or an affiliate.\nAlways read and follow all label directions, restrictions and precautions for\nuse. Products listed here may not be registered for sale or use in all states,\ncountries or jurisdictions.\n\nStatement under the Safe Harbor Provisions of the Private Securities\nLitigation Reform Act of 1995:  FMC and its representatives may from time to\ntime make written or oral statements that are \"forward-looking\" and provide\nother than historical information, including statements contained in this\npress release, in FMC's other filings with the SEC, and in presentations,\nreports or letters to FMC stockholders.\n\nIn some cases, FMC has identified these forward-looking statements by such\nwords or phrases as \"outlook\", \"will likely result,\" \"is confident that,\"\n\"expect,\" \"expects,\" \"should,\" \"could,\" \"may,\" \"will continue to,\" \"believe,\"\n\"believes,\" \"anticipates,\" \"predicts,\" \"forecasts,\" \"estimates,\" \"projects,\"\n\"potential,\" \"intends\" or similar expressions identifying \"forward-looking\nstatements\" within the meaning of the Private Securities Litigation Reform Act\nof 1995, including the negative of those words or phrases. Such\nforward-looking statements are based on our current views and assumptions\nregarding future events, future business conditions and the outlook for the\ncompany based on currently available information. The forward-looking\nstatements involve known and unknown risks, uncertainties and other factors\nthat may cause actual results to be materially different from any results,\nlevels of activity, performance or achievements expressed or implied by any\nforward-looking statement. These statements are qualified by reference to the\nrisk factors included in Part I, Item 1A of our Annual Report on Form 10-K for\nthe year ended December 31, 2025 (the \"2025 Form 10-K\"), the section captioned\n\"Forward-Looking Information\" in Part II of the 2025 Form 10-K and to similar\nrisk factors and cautionary statements in all other reports and forms filed\nwith the Securities and Exchange Commission (\"SEC\"). We wish to caution\nreaders not to place undue reliance on any such forward-looking statements,\nwhich speak only as of the date made.  Forward-looking statements are\nqualified in their entirety by the above cautionary statement.\n\nWe specifically decline to undertake any obligation, and specifically\ndisclaims any duty, to publicly update or revise any forward-looking\nstatements that have been made to reflect events or circumstances after the\ndate of such statements or to reflect the occurrence of anticipated or\nunanticipated events, except as may be required by law.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/fmc-corporation-submits-regulatory-dossier-for-rimisoxafen-the-industrys-first-dual-mode-of-action-herbicide-in-brazil-302891817.html\n(https://www.prnewswire.com/news-releases/fmc-corporation-submits-regulatory-dossier-for-rimisoxafen-the-industrys-first-dual-mode-of-action-herbicide-in-brazil-302891817.html)\n\nSOURCE FMC Corporation\n\n\n\nMedia contact: Kaitlin O'Shaughnessy, +1 (215) 299-6405, Kaitlin.OShaughnessy@fmc.com; Investor contact: Curt Brooks, +1 (215) 299-6137, Curt.Brooks@fmc.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS254577/FMC-CORPORATION-LOGO.jpg?id=OA2973644\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-28T20:30:00.307920688Z","server_sent_at_ms":1790627400307},"received_at":"2026-09-28T20:30:00.586Z","source_url":"https://www.prnewswire.com/news-releases/fmc-corporation-submits-regulatory-dossier-for-rimisoxafen-the-industrys-first-dual-mode-of-action-herbicide-in-brazil-302891817.html"},"analysis":{"id":"143349","press_release_id":"154590","analysis_json":{"industry":{"label":"Chemicals","sector":"Materials"},"redFlags":["rimisoxafen is not registered for sale or use anywhere; approval and launch timing remain uncertain"],"eventType":"regulatory","narrative":"FMC Corporation submitted the regulatory dossier for rimisoxafen to Brazilian authorities, its second global filing after the July 2026 U.S. EPA submission.\n\nRimisoxafen is billed as the industry's first dual mode of action herbicide (HRAC Groups 12 and 32), targeting resistant broadleaf weeds across Brazil's roughly 70 million hectares of corn and soybeans.\n\nIt is the third novel herbicide active ingredient FMC has advanced in Brazil, following Isoflex™ active and Dodhylex™ active; the product is not yet registered for sale and outcomes remain subject to regulatory review.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Pipeline progress: second global filing for first-in-class dual-MoA herbicide extends FMC's Brazil regulatory runway."},"keyFigures":{"drugName":"rimisoxafen","customDimensions":{"brazil_corn_hectares":"over 20 million hectares","global_filing_number":2,"brazil_soybean_hectares":"approximately 50 million hectares","novel_actives_submitted_in_brazil":3}},"quotedText":"Brazilian growers are facing complex weed resistance challenges that demand new and differentiated solutions","namedEntities":{"people":[{"name":"Leonardo Bastos","role":"Vice President and Chief Marketing Officer, FMC"},{"name":"Kaitlin O'Shaughnessy","role":"Media contact"},{"name":"Curt Brooks","role":"Investor contact"}],"products":["rimisoxafen","Isoflex™ active","Dodhylex™ active"],"companies":[{"name":"FMC Corporation","ticker":"FMC","relationship":"filer"},{"name":"U.S. Environmental Protection Agency","relationship":"regulator (July 2026 U.S. submission recipient)"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Regulatory dossier submission is a routine pipeline milestone, not an approval. Commercialization remains contingent on future regulatory review with no revenue impact yet."},"tickerRelevance":{"others":[],"primary":"FMC"},"globalImportance":22,"audienceRelevance":15,"eventTypeSecondary":["operations_update"],"importanceComponents":{"tickerTier":"large-cap","eventGravity":"routine-regulatory-submission","commercializationStage":"pre-approval"}},"event_type":"regulatory","event_type_secondary":["operations_update"],"sentiment":"bullish","material_impact_score":2,"narrative":"FMC Corporation submitted the regulatory dossier for rimisoxafen to Brazilian authorities, its second global filing after the July 2026 U.S. EPA submission.\n\nRimisoxafen is billed as the industry's first dual mode of action herbicide (HRAC Groups 12 and 32), targeting resistant broadleaf weeds across Brazil's roughly 70 million hectares of corn and soybeans.\n\nIt is the third novel herbicide active ingredient FMC has advanced in Brazil, following Isoflex™ active and Dodhylex™ active; the product is not yet registered for sale and outcomes remain subject to regulatory review.","key_figures":{"drugName":"rimisoxafen","customDimensions":{"brazil_corn_hectares":"over 20 million hectares","global_filing_number":2,"brazil_soybean_hectares":"approximately 50 million hectares","novel_actives_submitted_in_brazil":3}},"named_entities":{"people":[{"name":"Leonardo Bastos","role":"Vice President and Chief Marketing Officer, FMC"},{"name":"Kaitlin O'Shaughnessy","role":"Media contact"},{"name":"Curt Brooks","role":"Investor contact"}],"products":["rimisoxafen","Isoflex™ active","Dodhylex™ active"],"companies":[{"name":"FMC Corporation","ticker":"FMC","relationship":"filer"},{"name":"U.S. Environmental Protection Agency","relationship":"regulator (July 2026 U.S. submission recipient)"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-28T20:30:05.612Z","global_importance":22,"audience_relevance":15,"importance_components":{"tickerTier":"large-cap","eventGravity":"routine-regulatory-submission","commercializationStage":"pre-approval"}},"durationMs":4990,"modelName":"glm-5.3-flashx"}}